Focal Liver Lesions in Budd-Chiari Syndrome: Spectrum of Imaging Findings.
Francesco RizzettoDavide RutanniLuca Alessandro CarbonaroAngelo VanzulliPublished in: Diagnostics (Basel, Switzerland) (2023)
Budd-Chiari syndrome (BCS) is a rare clinical entity characterized by hepatic venous outflow obstruction, resulting in liver congestion and subsequent chronic parenchymal damage. This condition often leads to the development of focal liver lesions, including benign focal nodular hyperplasia-like regenerative nodules, hepatocellular carcinoma, and perfusion-related pseudo-lesions. Computed tomography, ultrasound, and magnetic resonance are the commonly employed imaging modalities for the follow-up of BCS patients and for the detection and characterization of new-onset lesions. The accurate differentiation between benign and malignant nodules is crucial for optimal patient management and treatment planning. However, it can be challenging due to the variable and overlapping characteristics observed. This review aims to provide a comprehensive overview of the imaging features and differential diagnosis of focal liver lesions in BCS, emphasizing the key findings and discussing the challenges associated with their interpretation, with the purpose of facilitating the subsequent clinical decision-making.
Keyphrases
- high resolution
- magnetic resonance
- computed tomography
- magnetic resonance imaging
- case report
- stem cells
- end stage renal disease
- decision making
- inferior vena cava
- chronic kidney disease
- newly diagnosed
- ejection fraction
- oxidative stress
- contrast enhanced
- prognostic factors
- cell therapy
- positron emission tomography
- patient reported outcomes
- mass spectrometry
- sensitive detection
- drug induced
- quantum dots
- patient reported